Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome
Abstract Background Metabolic inflammatory syndrome (MIS) is a novel concept in integrative healthcare that focuses on addressing metabolic disorders. The systemic immune-inflammatory index (SII) and systemic inflammatory response index (SIRI) are emerging biomarkers derived from blood cell counts....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-025-02611-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223773920264192 |
|---|---|
| author | Pin Jiang Jiexia Chen Jiehua Li |
| author_facet | Pin Jiang Jiexia Chen Jiehua Li |
| author_sort | Pin Jiang |
| collection | DOAJ |
| description | Abstract Background Metabolic inflammatory syndrome (MIS) is a novel concept in integrative healthcare that focuses on addressing metabolic disorders. The systemic immune-inflammatory index (SII) and systemic inflammatory response index (SIRI) are emerging biomarkers derived from blood cell counts. However, their associations with all-cause and cardiovascular mortality remain insufficiently explored. Methods This study utilized data from adult participants in the National Health and Nutrition Examination Survey (NHANES) between 2003 and 2018, all of whom had complete MIS-related data. SII and SIRI values were calculated based on blood test results. Kaplan–Meier survival curves and log-rank tests were employed to compare survival rates across quartiles of SII and SIRI. Weighted Cox proportional hazards regression models were used to evaluate the associations of SII and SIRI with all-cause and cardiovascular mortality. Nonlinear relationships and threshold effects were assessed using restricted cubic splines and segmented regression models. Receiver operating characteristic (ROC) and time-dependent ROC curves were generated to assess the predictive performance of SII and SIRI at various timepoints via area under the curve (AUC) analyses. Subgroup and sensitivity analyses were performed to examine these associations within specific populations. Results A total of 16,972 participants were included in the analysis. After adjusting for potential confounders, individuals in the highest quartile (Q4) of SII exhibited significantly increased risks of all-cause mortality [hazard ratio (HR): 1.28; 95% confidence interval CI 1.09–1.49; P = 0.002] and cardiovascular mortality (HR: 1.64; 95% CI 1.13–2.39; P = 0.009) compared to those in the lowest quartile (Q1). Similarly, participants in the highest quartile of SIRI demonstrated higher risks of all-cause mortality (HR: 1.56; 95% CI 1.26–1.92; P < 0.001) and cardiovascular mortality (HR: 2.14; 95% CI 1.46–3.13; P < 0.001). Both biomarkers emerged as independent predictors of mortality risk. J-shaped dose–response relationships were observed between log-SII and log-SIRI and the risks of all-cause and cardiovascular mortality (all P values for non-linearity were < 0.001). Both ROC and time-dependent ROC curve analyses indicated that log-SIRI had better prognostic performance for all-cause and cardiovascular mortality compared to log-SII. These findings were robust across subgroup and sensitivity analyses. Conclusions High levels of SII and SIRI were independently associated with increased risks of all-cause and cardiovascular mortality, with SIRI showing superior predictive performance. This study underscores the prognostic utility of SII and SIRI in patients with MIS and provides valuable insights into their roles in mortality risk assessment. |
| format | Article |
| id | doaj-art-e31c308a05444c319f783b0c92769bdd |
| institution | OA Journals |
| issn | 2047-783X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | European Journal of Medical Research |
| spelling | doaj-art-e31c308a05444c319f783b0c92769bdd2025-08-20T02:05:49ZengBMCEuropean Journal of Medical Research2047-783X2025-06-0130111610.1186/s40001-025-02611-6Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndromePin Jiang0Jiexia Chen1Jiehua Li2Department of General Medicine, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Medicine, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Medicine, The First Affiliated Hospital of Anhui Medical UniversityAbstract Background Metabolic inflammatory syndrome (MIS) is a novel concept in integrative healthcare that focuses on addressing metabolic disorders. The systemic immune-inflammatory index (SII) and systemic inflammatory response index (SIRI) are emerging biomarkers derived from blood cell counts. However, their associations with all-cause and cardiovascular mortality remain insufficiently explored. Methods This study utilized data from adult participants in the National Health and Nutrition Examination Survey (NHANES) between 2003 and 2018, all of whom had complete MIS-related data. SII and SIRI values were calculated based on blood test results. Kaplan–Meier survival curves and log-rank tests were employed to compare survival rates across quartiles of SII and SIRI. Weighted Cox proportional hazards regression models were used to evaluate the associations of SII and SIRI with all-cause and cardiovascular mortality. Nonlinear relationships and threshold effects were assessed using restricted cubic splines and segmented regression models. Receiver operating characteristic (ROC) and time-dependent ROC curves were generated to assess the predictive performance of SII and SIRI at various timepoints via area under the curve (AUC) analyses. Subgroup and sensitivity analyses were performed to examine these associations within specific populations. Results A total of 16,972 participants were included in the analysis. After adjusting for potential confounders, individuals in the highest quartile (Q4) of SII exhibited significantly increased risks of all-cause mortality [hazard ratio (HR): 1.28; 95% confidence interval CI 1.09–1.49; P = 0.002] and cardiovascular mortality (HR: 1.64; 95% CI 1.13–2.39; P = 0.009) compared to those in the lowest quartile (Q1). Similarly, participants in the highest quartile of SIRI demonstrated higher risks of all-cause mortality (HR: 1.56; 95% CI 1.26–1.92; P < 0.001) and cardiovascular mortality (HR: 2.14; 95% CI 1.46–3.13; P < 0.001). Both biomarkers emerged as independent predictors of mortality risk. J-shaped dose–response relationships were observed between log-SII and log-SIRI and the risks of all-cause and cardiovascular mortality (all P values for non-linearity were < 0.001). Both ROC and time-dependent ROC curve analyses indicated that log-SIRI had better prognostic performance for all-cause and cardiovascular mortality compared to log-SII. These findings were robust across subgroup and sensitivity analyses. Conclusions High levels of SII and SIRI were independently associated with increased risks of all-cause and cardiovascular mortality, with SIRI showing superior predictive performance. This study underscores the prognostic utility of SII and SIRI in patients with MIS and provides valuable insights into their roles in mortality risk assessment.https://doi.org/10.1186/s40001-025-02611-6Systemic immune inflammatory indexSystemic inflammatory response indexMetabolic inflammatory syndromeAll-cause mortalityCardiovascular mortality |
| spellingShingle | Pin Jiang Jiexia Chen Jiehua Li Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome European Journal of Medical Research Systemic immune inflammatory index Systemic inflammatory response index Metabolic inflammatory syndrome All-cause mortality Cardiovascular mortality |
| title | Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| title_full | Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| title_fullStr | Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| title_full_unstemmed | Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| title_short | Association of the systemic immune-inflammatory index and systemic inflammatory response index with all-cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| title_sort | association of the systemic immune inflammatory index and systemic inflammatory response index with all cause and cardiovascular mortality in individuals with metabolic inflammatory syndrome |
| topic | Systemic immune inflammatory index Systemic inflammatory response index Metabolic inflammatory syndrome All-cause mortality Cardiovascular mortality |
| url | https://doi.org/10.1186/s40001-025-02611-6 |
| work_keys_str_mv | AT pinjiang associationofthesystemicimmuneinflammatoryindexandsystemicinflammatoryresponseindexwithallcauseandcardiovascularmortalityinindividualswithmetabolicinflammatorysyndrome AT jiexiachen associationofthesystemicimmuneinflammatoryindexandsystemicinflammatoryresponseindexwithallcauseandcardiovascularmortalityinindividualswithmetabolicinflammatorysyndrome AT jiehuali associationofthesystemicimmuneinflammatoryindexandsystemicinflammatoryresponseindexwithallcauseandcardiovascularmortalityinindividualswithmetabolicinflammatorysyndrome |